Discover a non-invasive diagnostic model for primary Sjögren’s disease using salivary biomarkers, serum autoantibodies, and ...

The Phase 1 GALLOP study evaluating the investigational CAR-T therapy, CB-010, for treatment of lupus nephritis has launched.

Inc. (Nasdaq: VERA) today announced that on January 8, 2025, the Compensation Committee granted inducement awards consisting ...

Evercore ISI analyst Liisa Bayko maintained a Buy rating on Vera Therapeutics (VERA – Research Report) today and set a price target of $75.00.

Patients with systemic lupus erythematosus and hydroxychloroquine-related retinal toxicity had a greater prevalence of antiretinal autoantibodies. Patients with systemic lupus erythematosus (SLE) and ...

In a report released today, Sami Corwin from William Blair maintained a Buy rating on Cabaletta Bio (CABA – Research Report). The company’s ...

A non-invasive diagnostic model, based partially on saliva samples, distinguished between patients with and without Sjögren’s ...

Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative ...

To achieve the goals set out in its ‘Vision 2030’, argenx has set the following priorities for 2025: Expand the global ...

The blood test for those at high risk of lung cancer could lead to earlier detection and a "major reduction" in deaths, a ...

We described the first case reported in the literature of multiple myeloma in a young African woman with Systemic lupus and Sjögren Syndrome. The clinician should consider multiple myeloma in young ...

Blood testing people at high risk of lung cancer could reduce the number of deaths, a study has found. University of St ...